DayTwo
Latest round
- Series B
Last raised
- Oct 2019
Total raised
- $48M
Investors
- 8
About DayTwo
, operates as a microbiome-based precision medicine company that offers health monitoring and food recommending solutions for improving digestion, immunity, vitamin, production, and mental health. DayTwo provides food-as-medicine solutions and gut microbiome profiling solutions used to predict blood sugar response to foods, which can be accessed by patients via their artificial intelligence-based platform and mobile application, helping them to lower A1C levels, weight loss, reduced medication usage, increased energy levels, better sleep, and reduced stress. The company also provides personalized nutrition kits, which utilized stool samples to provide customized dietary recommendations for diabetic patients, along with microbiome analysis, precision nutrition, glucose and other vitals tracking, lifestyle coaching, medication management, and many more diabetic solutions. The company generates revenue by providing organizations with employer benefit programs and selected health plans.
Who invested in DayTwo
8 investors across 3 rounds
See all investors in DayTwo
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about DayTwo
Who invested in DayTwo?
DayTwo has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DayTwo raised?
DayTwo has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did DayTwo last raise money?
DayTwo's most recent round on record is a Series B, in Oct 2019.
What does DayTwo do?
, operates as a microbiome-based precision medicine company that offers health monitoring and food recommending solutions for improving digestion, immunity, vitamin, production, and mental health.
Where is DayTwo headquartered?
DayTwo is headquartered in Brentwood, US.
Which VCs invest in companies like DayTwo?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at DayTwo's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like DayTwo? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.